23AndMe CEO Anne Wojcicki was among the health data experts who convened to disc...
Despite the significant advances that have been made in the immuno-oncology fiel...
In this video interview, Dirk Borghs, CEO Datwyler Healthcare Solutions, talks t...
Rhenium (186Re) obisbemeda has been formulated for safe delivery of highly targe...
BD is a rare multisystem inflammatory vasculitis, which currently has no treatment.
The firms will sign a long-term contract that will help Marker fully focus on th...
The newly granted status helps Erasca facilitate the development and review of E...
The use of these current vaccines is important from a public health perspective ...
Bristol Myers Squibb will continue the development, manufacturing, and commercia...
The FDA granted Memo Therapeutics a fast track designation for its BK polyomavir...
Expansion of ODAIA’s platform will allow pharma companies to rapidly deliver lif...
Just a few months after the FDA approved sparsentan for IgA nephropathy, Travere...
"It’s critical the schools steward biomedical research in a way that preserves a...
“It was dehumanizing. It was terrifying. It was horrible not to get the care to ...
An investigation of research co-authored by Stanford President Marc Tessier-Lavi...
In the new approach, nurses involve mothers as they evaluate together whether ro...
